Dr. Meghan Azad and Dr. Vernon Dolinsky published a translational study about prenatal artificial sweetener exposure made possible by their interactions in DREAM and DEVOTION, and supported by a CHRIM Operating Grant. The study involved analysis of CHILD data and complementary experiments in mice and adipocyte cell cultures. It was a true team effort, with several clinical and basic science trainees contributing.
CLICK HERE for a summary co-released by CHILD/CHRIM/UofM
CLICK HERE for the journal article
What's New
All Articles
Dr. Payam Peymani Joins the DREAM Theme!
DREAM is pleased to welcome Payam Peymani (PharmD, PhD) to the DREAM theme! Dr. Peymani is a pharmacoepidemiologist whose research…
New iCARE research highlights kidney health in youth with type 2 diabetes
A new study from the iCARE cohort examined kidney health over two years in 188 youth living with type 2…
Canadian Lipid and Vascular Summit 2026
DREAM co-lead Dr. Vern Dolinsky and PhD student Khushali Trivedi attended the Canadian Lipid and Vascular Summit last week in…
15th Annual DREAM Symposium and DREAM Trainee Day
The DREAM theme is excited to announce the 2026 DREAM Diabetes Research Symposium: New Perspectives in Diabetes will be held…
Now Recruiting Participants for a Research Study!
The Type 1 Diabetes Exercise and Mentorship (TEAM) Trial is recruiting teenagers living with type 1 diabetes in the Winnipeg…
3 DREAM Researchers Receive Funding from 2026 CHRIM Operating Grants
Congratulations to Drs. Ayesha Saleem, Sukhpreet Tamana, and Jennifer Yamamoto who received close to $150,000 in funding from the 2026…